Recalls / Class II

Class IID-0400-2025

Product

Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01

Affected lot / code info

Lot #: 1MP24042, Exp 6/30/26

Why it was recalled

Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.

Recalling firm

Firm

Mckesson Medical-Surgical Inc. Corporate Office

Notification channel

N/A

Type

Voluntary: Firm initiated

Address

9954 Maryland Drive, Deep Run Iii Ste. 4000, Richmond, Virginia 23233

Distribution

Quantity

3

Distribution pattern

Distributed to Medical Facilities in MS and FL.

Timeline

Recall initiated

2025-04-25

FDA classified

2025-05-01

Posted by FDA

2025-05-07

Status

Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0400-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.